Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 05, 2023

SELL
$34.93 - $42.03 $7.81 Million - $9.39 Million
-223,449 Reduced 58.3%
159,811 $5.79 Million
Q4 2022

Feb 03, 2023

BUY
$31.09 - $37.88 $2,487 - $3,030
80 Added 0.02%
383,260 $13.7 Million
Q3 2022

Nov 01, 2022

SELL
$28.79 - $35.41 $963,601 - $1.19 Million
-33,470 Reduced 8.03%
383,180 $13 Million
Q2 2022

Aug 03, 2022

BUY
$25.33 - $34.25 $4.82 Million - $6.52 Million
190,434 Added 84.18%
416,650 $12.1 Million
Q1 2022

May 12, 2022

SELL
$28.51 - $32.9 $2.23 Million - $2.57 Million
-78,239 Reduced 25.7%
226,216 $7.31 Million
Q4 2021

Feb 04, 2022

BUY
$26.37 - $34.22 $8.03 Million - $10.4 Million
304,455 New
304,455 $8.88 Million
Q3 2018

Nov 05, 2018

SELL
$42.7 - $56.55 $2.59 Million - $3.43 Million
-60,670 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$44.1 - $59.85 $847,822 - $1.15 Million
19,225 Added 46.39%
60,670 $3.63 Million
Q1 2018

May 15, 2018

BUY
$37.15 - $46.9 $1.54 Million - $1.94 Million
41,445 New
41,445 $1.9 Million
Q4 2017

Feb 07, 2018

SELL
$36.4 - $42.6 $943,488 - $1.1 Million
-25,920 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$36.75 - $49.65 $952,560 - $1.29 Million
25,920
25,920 $1.04 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.94B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Lisanti Capital Growth, LLC Portfolio

Follow Lisanti Capital Growth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lisanti Capital Growth, LLC with notifications on news.